In a large and prospective cohort, higher polygenic risk is associated with higher risk and earlier age of onset for cardiometabolic disorders and cancer, and has added value to clinical risk scores in clinical disease prediction.
- Nina Mars
- Jukka T. Koskela
- Samuli Ripatti
